Close this search box.

October Series: Breast Radiotherapy: Evidencing the Future of Clinical Practice

Join us for this exciting breast radiotherapy webinar series during Breast Cancer Awareness Month, also known as ‘Pink October’. This series will provide valuable insights into the most recent evidence in breast radiotherapy, showcasing the TomoTherapy®, Radixact® and CyberKnife® Systems, which have been designed to improve patient treatment delivery and clinical outcomes. You can expect to learn about the ever-changing landscape of breast radiotherapy from experts from all over the world. Don’t miss out on this unique opportunity to gain knowledge and stay ahead of the curve!

Webinar series moderated by: Asal Rahimi, M.D., MS, Associate Professor, Chief of Breast Radiation, U.T. Southwestern Medical Center, Dallas, TX, USA

Click below for more information about each webinar

View Recording

If you are unable to access ON24, click here.
Breast-conserving therapy with radiation has been found to be as effective as mastectomy in overall survival and can reduce recurrence and mortality rates. Hypofractionated whole-breast irradiation can shorten treatment time without compromising safety. Partial-breast irradiation (PBI), including Brachytherapy, Intraoperative RT, and external beam radiotherapy (EBRT), is an option for selected patients with unique pros and cons. The EBRT accelerated partial breast irradiation (APBI) intensity-modulated radiotherapy (IMRT) Florence trial has shown positive results and long-term follow-up.

Dr. Salvestrini will highlight the crucial role of patient selection for PBI which should follow ESTRO, ASTRO and recent consensus recommendations. To define future directions, the pre-and post-operative multidisciplinary discussion should be mandatory for all breast cancer patients, biology should be definitively integrated into the decision-making process and radiation oncologists should always consider breast cancer as a heterogeneous disease. It is not a “one treatment fits all” disease.

Presenter: Viola Salvestrini, M.D., Radiation and Clinical Oncologist, Florence
University Hospital, Florence, Italy
Viola Salvestrini, M.D. is a consultant radiation and clinical oncologist at the Florence University Hospital. She is an active member of ESTRO, EORTC and is chair of the young group of AIRO. Dr. Salvestrini’s main fields of interest and research are breast cancer and head and neck cancer.

If you are unable to access ON24, click here.
Join us for an upcoming webinar with Dr. Chitapanarux, who has over ten years of experience using the TomoTherapy® System to treat breast cancer. During the webinar, Dr. Chitapanarux will cover the latest evidence for hypofractionated breast radiotherapy and the use of TomoDirect™ and TomoHelical™ Delivery. She will also share practical considerations and educational activities she is leading. This is an excellent opportunity for attendees to learn from an expert in the field and gain valuable insights into using the TomoTherapy System for treating breast cancer.


Presenter: Imjai Chitapanarux, M.D., Chiang Mai University Hospital, Chiang Mai, Thailand 

Dr. Chitapanarux serves as the deputy head and esteemed professor of the Radiology department at Chiang Mai University Hospital in Thailand. With a career spanning over two decades, she has made significant contributions to the field, particularly in the realm of hypofractionated radiation therapy for breast cancers, which she introduced to the hospital in 2004. Dr. Chitapanarux’s vast knowledge and experience have been evidenced by her extensive publication record, which includes over 100 works on the treatment of breast and head & neck cancers. 

If you are unable to access ON24, click here.
Baptist Health South Florida Cancer Care is the leading provider of radiation therapy in South Florida with comprehensive state-of-the-art radiotherapeutic technology. Locally advanced breast cancer constitutes 10-20% of all newly diagnosed breast cancer. Dr. Panoff will discuss the epidemiology and staging of locally advanced breast cancer and demonstrate the Radixact® & TomoTherapy® platform experience at Miami Cancer Institute. He will explain how the Radixact System is utilized amongst the complementary cutting-edge technologies in the setting of locally advanced breast cancer.

Presenter: Joseph Panoff, M.D., Miami Cancer Institute, Miami, FL, USA 

Dr. Panoff is a board-certified radiation oncologist at the Miami Cancer Institute and an FIU Herbert Wertheim Medical School Associate Professor. Previously, he was an Assistant professor of radiation oncology at the University of Miami Leonard Miller School of Medicine, teaching residents and medical students. His clinical specialty and research focus is on the use of radiation therapy to treat breast cancer. Dr. Panoff is the recipient of a National Institutes of Health grant to conduct clinical research in pediatric cancer. He is widely published in peer-reviewed medical journals, serves as an editorial reviewer for scientific publications, and is an invited speaker at healthcare symposiums. Dr. Panoff is the Chair of the Institutional Review Board for Research at MCI and the Chair of the Conflict-of-Interest Review Committee for Baptist Health South Florida.

Dr. Asal Rahimi is a California native and completed her undergraduate degree at The University of California San Diego (UCSD) in Biochemistry, followed by a master’s degree in applied Physiology, and then Medical School at The Chicago Medical School. She then pursued a Radiation Oncology Residency at The University of Virginia (UVA). Currently, she is an Associate Professor in the Department of Radiation Oncology at The University of Texas Southwestern (UTSW), the Division Chief of Breast Radiation, Associate Vice Chair of Diversity, Equity, and Inclusion, and serves as the Medical Director for the Clinical Trials Research Office in the Simmons Cancer Center. 

She also runs and writes her own Investigator Initiated clinical trials. Her clinical research is focused on reducing the volume of tissue being irradiated and the number of treatments for woman undergoing breast radiation for breast cancer using stereotactic partial breast irradiation techniques. (i.e.: Most recent trial utilizes 1 radiation treatment pre-operatively, compared to 33 treatments of radiation). She was one of the first investigators to use SPBI for breast cancer, and her research has helped develop these techniques. She has published and presented her research internationally, and commonly teaches other physicians on advanced breast radiation techniques. She also serves on the NCCN Breast Cancer Risk Reduction committee, which is the committee that develops national guidelines for Breast Cancer treatments and risk reduction in the United States. One of her greatest joys is treating and taking part in her patients’ journey and being there for them.